The Effect of Insulin Degludec on Risk of Symptomatic Nocturnal Hypoglycaemia in Subjects With Type 1 Diabetes and High Risk of Nocturnal Severe Hypoglycaemia
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 06 Apr 2018
At a glance
- Drugs Insulin degludec (Primary) ; Insulin aspart; Insulin glargine
- Indications Hypoglycaemia; Type 1 diabetes mellitus
- Focus Therapeutic Use
- Acronyms HypoDeg
- 03 Apr 2018 Planned End Date changed from 1 Dec 2017 to 1 Apr 2019.
- 03 Apr 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Apr 2019.
- 10 Jun 2017 Biomarkers information updated